Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Revenue | -2.88% | 0.73% | 9.25% | 1.38% | 13.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.88% | 0.73% | 9.25% | 1.38% | 13.13% |
| Cost of Revenue | 5.97% | 16.25% | 23.38% | -7.58% | 27.18% |
| Gross Profit | -4.02% | -1.22% | 7.26% | 2.45% | 11.54% |
| SG&A Expenses | -1.64% | 4.54% | 7.95% | 2.08% | 14.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.80% | 4.42% | 8.27% | -0.18% | 11.77% |
| Operating Income | -14.65% | -20.55% | 15.25% | 5.17% | 17.68% |
| Income Before Tax | -16.79% | -30.24% | 10.67% | -1.23% | 6.46% |
| Income Tax Expenses | -0.33% | -1,020.05% | -14.61% | 19.08% | 35.69% |
| Earnings from Continuing Operations | -21.14% | -15.65% | 17.37% | -6.10% | 0.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -42.74% | -8.78% | 61.11% | -12.76% | 58.67% |
| Net Income | -21.37% | -15.77% | 19.84% | -6.17% | 1.26% |
| EBIT | -14.65% | -20.55% | 15.25% | 5.17% | 17.68% |
| EBITDA | -9.95% | -12.98% | 16.65% | 7.24% | 19.15% |
| EPS Basic | -21.25% | -15.98% | 19.56% | -6.77% | 1.00% |
| Normalized Basic EPS | -10.17% | -18.45% | 3.45% | 3.64% | 5.36% |
| EPS Diluted | -21.43% | -15.03% | 20.00% | -6.93% | 1.45% |
| Normalized Diluted EPS | -9.72% | -18.47% | 3.71% | 3.65% | 5.94% |
| Average Basic Shares Outstanding | -0.16% | 0.25% | 0.22% | 0.64% | 0.25% |
| Average Diluted Shares Outstanding | -0.65% | 0.26% | -0.06% | 0.63% | -0.30% |
| Dividend Per Share | 9.09% | 9.09% | 10.00% | 10.00% | 10.00% |
| Payout Ratio | 0.38% | 0.31% | -0.08% | 0.18% | 0.09% |